Abeona Therapeutics Inc. Quarterly report pursuant to Section 13 or 15(d)

COMMITMENTS AND CONTINGENCIES (Tables)

6 Months Ended

Jun. 30, 2020

Components of lease cost are as follows:

SCHEDULE OF COMPONENTS OF LEASE COST

	For the three months ended June 30,		For the three months ended June 30,		For the six months ended June 30,		For the six months ended June 30,
	2020		2019		2020		2019
Operating lease cost	$	434,000	$	434,000	$	868,000	$	723,000
Variable lease cost	$	92,000	$	86,000	$	175,000	$	159,000
Short-term lease cost	$	6,000	$	34,000	$	24,000	$	81,000

The following table presents information about the amount and timing of cash flows arising from operating leases as of June 30, 2020:

Maturity of lease liabilities:
2020, remainder	$	851,000
2021		1,713,000
2022		1,727,000
2023		1,741,000
2024		1,781,000
Thereafter		1,885,000
Total undiscounted operating lease payments		9,698,000
Less: imputed interest		2,224,000
Present value of operating lease liabilities	$	7,474,000

Balance sheet classification:
Current portion of lease liability	$	1,706,000
Long-term lease liability		5,768,000
Total operating lease liabilities	$	7,474,000

Other information:
Weighted-average remaining lease term for operating leases		67 months
Weighted-average discount rate for operating leases		9.6%